Both Pfizer and BioNTech issued a joint press release declaring that the U.S. Food and Drug Administration (FDA) granted Priority Review Designation for the Biologics…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.